Teva Pharmaceutical Industries Ltd (ADR) Share Price Nasdaq
Equities
US8816242098
Pharmaceuticals
Sales 2024 * | 15.86B 1,324B | Sales 2025 * | 16.4B 1,368B | Capitalization | 15.83B 1,322B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 128B | Net income 2025 * | 1.44B 120B | EV / Sales 2024 * | 1.93 x |
Net Debt 2024 * | 14.82B 1,237B | Net Debt 2025 * | 12.25B 1,022B | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
11.2
x | P/E ratio 2025 * |
10.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Ltd (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/23/01 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/19/22 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/15/01 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/20/09 |
Sol Barer
CHM | Chairman | 76 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |